Vitamin B/Vascular Disease Disclaimer "Immediately Adjacent" To Claim
This article was originally published in The Tan Sheet
Executive Summary
An FDA disclaimer describing the evidence of B vitamins' role in reducing vascular disease risk as "inconclusive" must be "immediately adjacent to, and directly beneath" a health claim negotiated by dietary supplement firms and the agency.
You may also be interested in...
Vitamin B Health Claim Without Total Diet Reference "Misleading" - FDA
A qualified vitamin B/vascular disease health claim that omits a statement about diets low in saturated fat and cholesterol is misleading, FDA concludes.
Vitamin B/Vascular Disease Qualified Claim Excludes Specific Nutrient Levels
Dietary supplements carrying a qualified health claim for vitamin B/vascular disease are prohibited from identifying daily intake levels of the nutrients necessary for disease risk reduction, FDA announced Nov. 28 in authorizing a claim.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC